FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YANG, C.-R.
Right arrow Articles by BOOTHMAN, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YANG, C.-R.
Right arrow Articles by BOOTHMAN, D. A.
(The FASEB Journal. 2000;14:379-390.)
© 2000 FASEB

Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation

CHIN-RANG YANG*, CARMELL WILSON-VAN PATTEN*, SARAH M. PLANCHON*, SHELLY M. WUERZBERGER-DAVIS{dagger}, THOMAS W. DAVIS*, SCOTT CUTHILL{ddagger}, SHIGEKI MIYAMOTO{dagger} and DAVID A. BOOTHMAN*1

* Departments of Radiation Oncology and Pharmacology and the Ireland Comprehensive Cancer Center, Laboratory of Molecular Stress Responses, Case Western Reserve University, Cleveland, Ohio 44106-4942, USA;
{dagger} Department of Pharmacology and University of Wisconsin Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin 53792, USA; and
{ddagger} DeRoche Discovery Welwyn, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom

1Correspondence: Departments of Radiation Oncology and Pharmacology and the Ireland Cancer Center, Laboratory of Molecular Stress Responses, Case Western Reserve University, 10900 Euclid Ave. (BRB 326), Cleveland, OH 44106-4942, USA. E-mail: dab30{at}po.cwru.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Regulation of transcriptional responses in growth-arrested human cells under conditions that promote potentially lethal damage repair after ionizing radiation (IR) is poorly understood. Sp1/retinoblastoma control protein (RCP) DNA binding increased within 30 min and peaked at 2–4 h after IR (450–600 cGy) in confluent radioresistant human malignant melanoma (U1-Mel) cells. Increased phosphorylation of Sp1 directly corresponded to Sp1/RCP binding and immediate-early gene induction, whereas pRb remained hypophosphorylated. Transfection of U1-Mel cells with the human papillomavirus E7 gene abrogated Sp1/RCP induction and G0/G1 cell cycle checkpoint arrest responses, increased apoptosis and radiosensitivity, and augmented genetic instability (i.e., increased polyploidy cells) after IR. Increased NF-{kappa}B DNA binding in U1-Mel cells after IR treatment lasted much longer (i.e., >20 h). U1-Mel cells overexpressing dominant-negative I{kappa}B{alpha} S32/36A mutant protein were significantly more resistant to IR exposure and retained both G2/M and G0/G1 cell cycle checkpoint responses without significant genetic instability (i.e., polyploid cell populations were not observed). Nuclear p53 protein levels and DNA binding activity increased only after high doses of IR (>1200 cGy). Disruption of p53 responses in U1-Mel cells by E6 transfection also abrogated G0/G1 cell cycle checkpoint arrest responses and increased polyploidy after IR, but did not alter radiosensitivity. These data suggest that abrogation of individual components of this coordinate IR-activated transcription factor response may lead to divergent alterations in cell cycle checkpoints, genomic instability, apoptosis, and survival. Such coordinate transcription factor activation in human cancer cells is reminiscent of prokaryotic SOS responses, and further elucidation of these events should shed light on the initial molecular events in the chromosome instability phenotype.—Yang, C.-R., Wilson-Van Patten, C., Planchon, S. M., Wuerzberger-Davis, S. M., Davis, T. W., Cuthill, C., Miyamoto, S., Boothman, D. A. Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation.


Key Words: PLDR • Sp1 • retinoblastoma control proteins • NF-{kappa}B • p53 • ionizing radiation • genomic instability • aneuploid/polyploid • apoptosis


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
HUMAN MALIGNANT MELANOMA is often highly metastatic and radioresistant (1 , 2) . An established human melanoma cell line (U1-Mel) that showed extreme radioresistance (1) and high rates of PLDR (potential lethal damage repair) (3) has been used as a model system for investigating resistance to ionizing radiation (IR).

To elucidate mechanism(s) of radioresistance, we previously isolated three known IR-inducible transcripts (xips) by differential hybridization [i.e., thymidine kinase (TK), tissue-type plasminogen activator (t-PA), and DT diaphorase (NQO1)] from confluence-arrested U1-Mel cells during PLDR responses (4) . While investigating the IR activation of transcription factors (TFs) binding to the TK and t-PA promoters, we discovered that Sp1/RCPs (retinoblastoma control proteins) binding to an Sp1 consensus sequence site was enhanced in confluent human normal and neoplastic cells after IR (5) . More important, we showed that Sp1/RCP binding within the TK promoter correlated with the IR induction of TK transcript and enzyme activity and also with the induction of a number of immediate early growth response proto-oncogenes (IEGs, such as c-jun, c-fos, c-myc, egr-1, TGF-ß, TK) (5 6 7) . The Sp1 binding site (GGGCGG, i.e., a GC box) is one type of RCE (retinoblastoma control element). The RCE can be the target of transcriptional regulation by a series of proteins that are regulated by the retinoblastoma protein (pRb) (8) . There are at least three nuclear RCPs (retinoblastoma control proteins) that complex with these elements in vitro, and the RCE-RCP complex may play a role in pRb protein-regulated transcription (9 10 11) . The Sp1 protein is only one type of RCP that may bind and regulate RCE-containing genes, usually causing transcriptional down-regulation when binding alone (8) . Sp1-mediated transcription is thought to be stimulated by phosphorylation via protein kinases, such as c-abl, but are also regulated by pRb; transient overexpression of hypophosphorylated pRb can stimulate Sp1/RCP binding (12) .

The other known TFs that are activated after IR are p53 (reviewed in ref 13 ) and nuclear factor-kappa B (NF-{kappa}B) (5 , 14) . Binding of NF-{kappa}B to the t-PA promoter (as shown by primer extension DNase I footprinting) corresponded very closely to the IR-mediated t-PA transcript induction (4 , 15 , 16) , but not to the induction of TK (6) in U1-Mel cells.

The purpose of this study was to further characterize mechanisms of coordinate IR activation of Sp1, NF-{kappa}B, and p53 in confluent U1-Mel cells under conditions that promote PLDR. Such studies may elucidate a mammalian equivalent of the prokaryotic SOS response (17) . We show that Sp1 and NF-{kappa}B DNA binding activity increased after low doses (clinically relevant) of IR. p53 activation, in contrast, did not occur in confluent U1-Mel cells unless very high doses of IR were used. The radiosensitivity of U1-Mel cells was considerably altered by disruption of the regulation of Sp1-pRb (by E7 transfection) or NF-{kappa}B (by its cytoplasmic inhibitor, I{kappa}B{alpha} S32/36A dominant negative mutant), but not by disruption of p53 (by E6 transfection). The cell cycle alterations of E6/E7-transfected U1-Mel cells and dramatically increased genomic instability (measured as increased polyploid cell populations) after IR were also observed.

Sp1, I{kappa}B{alpha}, and p53 are substrates in vitro for DNA-dependent protein kinase (DNA-PK) (18 19 20 21) , which is required for the repair of DNA double-strand breaks (reviewed in ref 22 ). The possibility that DNA-PK is an upstream coordinate regulator of Sp1, NF-{kappa}B (via I{kappa}B{alpha}, as proposed in refs 19 , 21 ), and p53 (as proposed in ref 20 ) is also discussed.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Cell culture, irradiation conditions, and survival (PLDR) assays
Human radioresistant malignant melanoma (U1-Mel) cells were cultured and maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS) as described (23 , 24) . On confluence arrest, cells were placed in DMEM containing 0.2% FBS overnight (16–18 h) and <6% tritiated thymidine-labeled nuclei were observed (4 , 23 , 24) . Cells were treated with various doses of IR using a 137Cs source (dose rate: 6 Gy/min). Preparation of nuclear extracts, DNA band shift assays, and Western blot analyses were performed as described below. PLDR ability (or enhanced cell survival) was determined by colony-forming assays (25) . Briefly, after irradiation, cells were incubated for 4 h to allow for PLDR, trypsinized, serially diluted, and then plated in DMEM containing 10% FBS as described previously (25) . Experiments were performed at least three times, each in duplicate. All experiments were performed using mycoplasma-free cultures. We noted that mycoplasma-contaminated U1-Mel cells showed increased basal levels and loss of IR induction of Sp1 and NF-{kappa}B DNA binding, as well as basal expression of all xips (4) .

Stable transfection, measurements of cell cycle distribution, and apoptosis
Log-phase U1-Mel cells were seeded at low cell density (1x105 cells/100 mm plate) in DMEM containing 10% FBS, then incubated with retroviral expression systems containing pLXSN vector alone (vec1), pLXSN-E6, or pLXSN-E7 for control, human papillomavirus E6, and E7 gene overexpression, respectively. After 4 h, media containing virus were removed and replaced with DMEM containing 10% FBS. After 48 h, infected cells were selected for over 2 wk in DMEM containing 500 µg/ml G418 (neomycin). Individual clones were isolated and maintained in DMEM containing 200 µg/ml G418. For overexpression of the I{kappa}B{alpha} S32/36A mutant protein, U1-Mel cells were transfected with pCMX vector alone (vec2) or pCMX-I{kappa}B{alpha} S32/36A mutant (26) , and individual clones were isolated. I{kappa}B{alpha} mutant overexpression was confirmed by Western immunoblot analyses (data not shown). The wild-type p53 status of nontransfected and transfected U1-Mel cells was confirmed using SSCP analyses as described by the manufacturer (Clontech, Inc.) (data not shown). All transfected U1-Mel clones described above had similar doubling times, estimated from growth curves to be 27 ± 2 hrs.

At select times post-IR, adherent U1-Mel-vec1, -E6, -E7, -vec2, or -I{kappa}B{alpha} S32/36A cells were harvested by trypsinization. Floating cells were also collected from media by centrifugation. Adherent and floating cells were then stained with 50 µg/ml propidium iodide (PI) in phosphate-buffered saline with 0.5% Nonidet P-40 and RNase A as described (27) . Cells were analyzed using a Becton Dickinson FACStar flow cytometer. Data were analyzed by ModFit LT (Verity Software House). Apoptotic cells were analyzed as a sub-G0/G1 (<2N) cell population after citric acid washing (27) and apoptosis was confirmed by evaluating the percentage of apoptotic bodies, using Hoescht 33238 dye staining and other morphology changes as described (27) . The emergence of polyploid cell populations were grouped and quantified as >4N DNA content. Experiments were performed at least three times, each in duplicate.

Preparation of nuclear extracts, DNA band shift assays, and Western immunoblot analyses
Nuclear extracts were prepared at various times and/or after various doses of IR (5) . DNA band shift and Western immunoblot assays were performed as described (5 , 6) . Oligomers containing specific DNA binding sites were: Sp1, 5'-GATCGATCGGGGCGGGGCGATC-3'; NF-{kappa}B, 5'-GATCGAGGGGACTTTCCCTAGC-3'; p53, 5'-GATCCGGACATGCCCGGGCATGTCCG-3'; Oct-1, 5'-GATCGAATGCAAATCACTAGCT-3'. Sp1 (sc-59X) and p53 (sc-126X, to wild-type p53) antibodies used for supershift assays were purchased from Santa Cruz Biochemicals (San Diego, Calif.). Oct-1 DNA binding activity remained unchanged after IR (5) and was used as loading controls throughout the experiments described above (data not shown). DNA band shift assays were quantified by PhosphorImager (Molecular Dynamics) analyses. Western immunoblots of nuclear extracts were analyzed for alterations in Sp1, p53, and pRb proteins using the appropriate antibodies [Sp1 (PEP2), p53 (DO-1, HRP conjugate), and pRb (C-15)] purchased from Santa Cruz Biochemicals. Nuclear extract (10 µg) from nonirradiated or irradiated (various doses, various times post-IR) quiescent U1-Mel cells was separated on 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels, transferred to immobilon-P membranes (Millipore), probed using antibodies against p53, Sp1, or pRb (described above), and detected by enhanced chemiluminescence (ECL, Amersham). All experiments were repeated at least three times.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Increased DNA binding of Sp1/RCP, NF-{kappa}B, and p53 in human U1-Mel cells after IR
We previously observed increases in immediate early genes after IR in U1-Mel cells (7) . Our goal was to determine whether Sp1/RCP transcription factor (TF) DNA binding correlated with IR-inducible endogenous IEG expression, since RCP-dependent regulation of some IEGs (i.e., c-fos, c-myc, TGF-ß) has been demonstrated (9 10 11) . We primarily examined Sp1 consensus site DNA binding (Figs. 1A, B ),but similar responses were noted using the RCE consensus site (data not shown). Increases in DNA binding corresponding to the appearance of shifted bands 1a and 1b occurred shortly after a 450 cGy IR treatment; in fact, slight increases were noted at t = 0, which was ~15 min after exposure and analyses. In contrast, increases in TF binding corresponding to shifted band 2 after 450 cGy were not apparent until 30 min, then dramatically increased over the next 90 min until peak levels at 2 h (four- to fivefold increases) (Fig. 1A ) were observed. Peak DNA binding activities for all TF complexes [i.e., Sp1 (band 1a) and the remaining RCPs (bands 1b and 2)] were observed at 2 h (Fig. 1A ) after 450–600 cGy (Fig. 1B ). At higher doses of IR, induction of Sp1 binding was not noted. A low level of nonspecific DNA binding comigrating with band 2 was observed, as evident when Sp1 cold competitor DNA was added (Fig. 1B ). Similar Sp1 binding patterns (i.e., formation of shifted bands 1a, 1b, and 2, Figs. 1 and 2 ) in log-phase nonirradiated cells have been described (12 , 28) . In addition, a minor band (marked with an asterisk on Fig. 1B ) was sometimes visible. The time and dose response of Sp1/RCP DNA binding induction (Fig. 1A, B ) closely paralleled the induction of endogenous c-fos, c-myc, c-jun, egr-1, and TK transcripts in confluent U1-Mel cells (4 , 7) . Induction of these IEGs (transcript levels) was observed up to 600 cGy between 15 min and 4 h post treatment, then rapidly declined both with time and with higher doses of IR (4 , 7) . Similarly, increases in Sp1/RCP DNA binding were not observed after higher doses (over 750 cGy) of IR (Fig. 1B ). Increases in TFs binding to AP-1 consensus sites were not observed.




View larger version (162K):
[in this window]
[in a new window]
 
Figure 1. Modulation of Sp1/RCP, NF-{kappa}B and p53 DNA binding after IR in human U1-Mel cells. Nuclear extracts from irradiated or nonirradiated confluent U1-Mel cells were examined for activation of transcription factor binding using DNA band shift assays as described in Materials and Methods. A) Time course (in hours) of proteins binding to the Sp1 consensus site before and after 450 cGy; B) effect of various doses of IR (0–1200 cGy) on proteins binding to the Sp1 consensus site at 2 h after IR; C) time course (in h) of NF-{kappa}B DNA binding activity after 450 cGy; D) effect of various doses of IR (0–1200 cGy) on NF-{kappa}B DNA binding at 12 h postirradiation; E) time course and dose response of nuclear p53 DNA binding activity. Addition of p53 antibody (E) blocked IR-induced DNA binding. Equal amounts of protein were loaded in each lane as determined by Bradford assays. In addition, TF binding to AP-1 and Oct-1 oligos remained unchanged at various times and doses after IR (data not shown), as described previously (5) . Gels are representative of experiments performed at least three times. 100 cGy = 1.0 Gy.



View larger version (50K):
[in this window]
[in a new window]
 
Figure 2. Composition of the Sp1/RCP complex binding to DNA and changes in Sp1 and pRb proteins after IR. Quiescent U1-Mel Cells were treated with IR and analyzed as described in Materials and Methods. A) DNA supershift analyses were performed using monoclonal antibodies to Sp1 or pRb and nuclear extracts from nonirradiated and X-irradiated U1-Mel cells. Lanes 1, 4, 7: no antibody added; lanes 2, 5, 8: addition of 1 µg Sp1 monoclonal antibody; lanes 3, 6, 9: addition of 1 µg pRb monoclonal antibody. Nuclear extracts from nonirradiated and irradiated U1-Mel cells were analyzed by Western immunoblotting as described in Materials and Methods. B) Dose response of Sp1 protein level and phosphorylation (Sp1-P) status 2 h postirradiation. C) Dose response of pRb protein level and phosphorylation (pRb-P) status 2 h after IR. D) Dose response of p53 protein levels at 2 h postirradiation. Experiments were performed at least three times and representative gels are shown.

Increases in NF-{kappa}B DNA binding activity were also observed (Figs. 1C, D ). Unlike Sp1/RCP binding, increases in NF-{kappa}B binding were noted after 30 min and observed continuously for the next 24 h after 450 cGy. Peak DNA binding activities (two- to threefold increases) were noted between 12 and 24 h (Fig. 1C ) with 300–450 cGy (Fig. 1D ). After 48 h, NF-{kappa}B binding decreased to nonirradiated control levels. Aside from lowered DNA binding at the 6 h time point due to loading, Oct-1 TF binding was not altered by IR exposure. Increased NF-{kappa}B DNA binding corresponded in time to endogenous late IR-response gene expression in U1-Mel cells, such as t-PA (4 , 15 , 16) , but not to the induction of IEGs. We previously observed that IR-inducible t-PA expression correlated to NF-{kappa}B binding within the promoter region of t-PA gene by primer extension DNase I footprinting (16) . Together, these data suggest that t-PA may be controlled in part by NF-{kappa}B.

Alterations in p53 after IR have been well documented (29) (reviewed in ref 13 ). We examined the DNA binding activity of p53 to its corresponding consensus site in confluent U1-Mel cells before and after IR exposure. p53 DNA binding activity was greatly increased 2 h after a high dose (1200 cGy) of IR treatment, but increased only slightly at lower doses (450 cGy) (Fig. 1E ). Peak p53 binding was consistently observed 2 h after high doses of IR. Addition of antibodies that are directed against wild-type p53 in band shift assays blocked p53-mediated DNA binding (Fig. 1E ). In contrast, mouse IgG had no effect on IR-activated p53 DNA binding activity (data not shown).

Composition of Sp1/RCP complexes
We then investigated the composition of TFs binding to the Sp1 site using monoclonal or polyclonal antibodies against Sp1 or pRb (Fig. 2A ). Antibodies against Sp1 caused a supershift of band 1a (see arrow in lanes 2, 5, and 8, Fig. 2A ) and weakened, but did not eliminate, DNA binding at bands 1b and 2. These data suggest that Sp1 (band 1a) may facilitate the binding of other RCPs (bands 1b and 2) as previously proposed (12 , 28 , 30) . Binding within the supershifted band increased after IR treatment (compare lane 2 as to nonirradiated nuclear extract with lanes 5 and 8, given 300 and 450 cGy, respectively) (Fig. 1) . Addition of antibodies directed against pRb (Fig. 2A ) had no effect on Sp1/RCE DNA binding (lanes 3, 6, and 9; Fig. 2A ), indicating that pRb was not a component of the Sp1/RCP TF complexes observed in Fig. 1A, B . These data are consistent with previous reports that pRb expression affects binding of Sp1 and RCPs to their respective consensus sequences, but pRb itself is not a direct component of the DNA binding complex (12 , 28 , 30) .

Alterations in nuclear protein levels of Sp1, pRb, and p53 and phosphorylation status of pRb and Sp1 In U1-Mel cells after IR
Immediate increases in the phosphorylated form of Sp1 (Sp1-P band, Fig. 2B ) (18 , 31) were noted in confluent U1-Mel cells after IR, with peak levels appearing in 2 h. Scanning densitometry revealed that nearly 20% of the total Sp1 protein was phosphorylated (shifted upwards) in the nuclei of confluent U1-Mel cells after doses of IR between 300 and 600 cGy. Higher doses of IR (>750 cGy) resulted in very little phosphorylation of Sp1 (Fig. 2B ) compared to basal control levels, consistent with a lack of Sp1 TF binding (Fig. 1B ). These data are consistent with previous reports that phosphorylation of Sp1 increased its transcriptional activity (31 , 32) . The phosphorylation status of pRb (Fig. 2C ) was not altered after IR, and virtually all of the pRb protein present in the nucleus of quiescent U1-Mel cells was in the hypophosphorylation form. These data suggest that increases in Sp1 DNA binding in U1-Mel cells after IR may be causally related to increased Sp1 phosphorylation (31 , 32) and may regulate xips. Furthermore, coordinate increases in Sp1 and NF-{kappa}B DNA binding may regulate gene expression in a manner similar to that proposed for HIV gene regulation (33) .

We also examined alterations in the nuclear levels of p53 protein in U1-Mel cells after IR (Fig. 2D ). U1-Mel cells express wild-type p53 protein as determined by SSCP analyses (data not shown). Nuclear p53 protein levels greatly increased in U1-Mel cells 2 h after 1200 cGy, but only slight increases were noted after 450 cGy (Fig. 2D ). Increases in nuclear p53 protein levels after high doses of IR were consistent with increases in IR-activated p53 DNA binding activity (Fig. 1E ), as described previously (34 , 35) .

Disruption of Sp1, NF-{kappa}B, and p53 regulation result in various cellular responses after IR
To further understand the roles of these TFs in IR responses, we transfected U1-Mel cells with E6 (to block p53 responses) or E7 (to block pRb regulation of Sp1) human papillomavirus genes under the control of CMV promoters as described in Materials and Methods. An estimated fivefold increase in basal Sp1/RCP DNA binding by PhosphorImager analyses in E7-transfected U1-Mel (U1-Mel-E7) cells was observed (Fig. 3A ). Sp1/RCP DNA binding remained unaltered in U1-Mel-E7 cells after 5 or 10 Gy, in contrast to IR-activated binding previously observed in parental U1-Mel or vector-alone transfected U1-Mel cells (Fig. 1B ). Thus, loss of pRb function due to E7 transfection resulted in an abrogation of IR-mediated Sp1/RCP DNA binding activation. In a separate experiment using pRb-deficient human bladder cancer cells (36) , higher Sp1 DNA basal binding and no induction after IR were also observed (C. R. Yang et al., unpublished data). U1-Mel-E7 cells showed loss of radioresistance (i.e., loss of PLDR) compared to U1-Mel-vec1 (vector alone) or U1-Mel-E6, as measured using colony-forming assays (Fig. 3B ). The D0 values were 220 cGy for U1-Mel-vec1 or U1-Mel-E6 compared to 180 cGy for U1-Mel-E7. Not only was the shoulder region of IR-treated, E7-transfected U1-Mel cells statistically different (P<0.05 for 500 cGy) from E6- or vector-alone transfected U1-Mel cells, but exponential IR-mediated cell killing was also influenced. Loss of survival mediated by IR under these confluent conditions presumably was due to dramatically increased apoptosis in IR-treated U1-Mel-E7 cells compared to U1-Mel-vec1 or U1-Mel-E6 cells (Table 1 ); apoptotic cell populations were determined using flow cytometry, Hoescht dye staining, and by monitoring changes in morphology as described in Materials and Methods. The plating efficiency of U1-Mel-E6 cells was dramatically reduced (3% vs. 50% in U1-Mel-vec1 or -E7). However, those cells that did attach retained E6 expression and were not altered in their sensitivity to IR compared to U1-Mel-vec1 cells (Fig. 3B ). In contrast, U1-Mel cells overexpressing the I{kappa}B{alpha} S32/36A mutant protein (U1-Mel-I{kappa}B{alpha} S32/36A, which blocks nuclear translocation of NF-{kappa}B (37) , showed enhanced radioresistance (as measured by PLDR) compared to U1-Mel-vec2 (vector alone) cells (Fig. 3C ).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 3. Analyses of stably transfected U1-Mel cells expressing E6, E7, or dominant-negative I{kappa}B{alpha} S32/36A mutant proteins after IR. A) Human U1-Mel cells were stably transfected with the human papillomavirus E7 gene as described in Materials and Methods. Cells were treated with or without 5 Gy or 10 Gy of IR (1 Gy = 100 cGy) and nuclear extracts were prepared 2 h postirradiation. Extracts were then analyzed for Sp1/RCP DNA binding activity as in Fig. 1 . f = free 32P-labeled Sp1 consensus site DNA probe. B) Survival (PLDR) assays of E6-transfected (U1-Mel-E6), E7-transfected (U1-Mel-E7), and vector alone (U1-Mel-vec1) U1-Mel cells were performed as described in Materials and Methods. Open circle: U1-Mel-vec1; filled circle: U1-Mel-E6; filled square: U1-Mel-E7. C) Survival assays of U1-Mel cells overexpressing the I{kappa}B{alpha} S32/36A mutant protein (U1-Mel-I{kappa}B{alpha} S32/36A) or transfected with vector alone (U1-Mel-vec2) were performed as described in Materials and Methods. Open circle: U1-Mel-vec2; filled square: U1-Mel- I{kappa}B{alpha} S32/36A. All experiments were performed at least three times, each in duplicate. Data points are mean ± SE, which are sometimes smaller than the symbols. Statistical evaluations were performed using the Student’s t test; values for 95% and 99% confidence limits were expressed as *P = <0.05 and **P = <0.01, respectively, compared to vector cells alone.


View this table:
[in this window]
[in a new window]
 
Table 1. Cell cycle distribution and apoptosis in transfected human U1-Mel cells 48 h after ionizing radiationa

Both IR-treated U1-Mel-E6 and U1-Mel-E7 cells demonstrated a lack of G0/G1 cell cycle checkpoint arrest, a concomitantly enhanced accumulation of irradiated cells in G2/M, and increased population of polyploidy cells compared to U1-Mel-vec1 cells after IR (Table 1) . No obvious cell cycle checkpoint differences or increases in apoptosis or polyploid cell populations were observed in U1-Mel-I{kappa}B{alpha} S32/36A cells compared to U1-Mel-vec2 (vector alone) cells after IR. A similar increase in polyploid cell populations was demonstrated in p21-deficient colon cancer cells after IR (38) . These data strongly suggest that the consequence of deregulation of pRb, Sp1, or p53 to the surviving cells after IR appears to be a dramatic loss of cell cycle checkpoint responses and a concomitant dramatic increase in genomic instability, as measured by the emergence of polyploid U1-Mel cells (Table 1) .


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The role of IR-inducible proteins in DNA repair, genomic instability, apoptosis, survival, and carcinogenesis is poorly understood. Links between these proteins and signaling from the nucleus to the cytoplasm after DNA damage remain unclear. Confluence-arrested human melanoma U1-Mel cells were chosen for their extreme radioresistance (1) and high rates of PLDR after IR (3) . For example, after 2–10 Gy, confluent U1-Mel cells demonstrated survival increases of three- to fivefold, respectively, in 2–8 h if held in a quiescent state before replating for colony-forming ability. The experiments performed here were to better understand the transcriptional responses of these cells during DNA repair and survival recovery responses (i.e., PLDR), since we previously described the X-ray induction of endogenous TK, IEGs, and t-PA (4 , 6 , 7 , 15) transcripts and proteins in U1-Mel cells. Our previous data suggest that IR induces only a certain subset of genes (including many of the IEGs), resulting in the stimulation of transcripts/proteins perhaps needed for DNA repair or cell cycle checkpoints (7) .

Activation of NF-{kappa}B DNA binding appears to occur later than Sp1/RCP DNA binding after IR (Fig. 1) . However, activation of both TFs demonstrated similar dose response kinetics, being induced at doses up to 600 cGy but declining with higher doses of IR. NF-{kappa}B and Sp1 peak DNA binding affinities/levels occurred at different times after IR treatment (Fig. 1) . Although NF-{kappa}B DNA binding activity appeared within the first 1–2 h after IR, peak DNA binding activity and expression of the NF-{kappa}B-responsive, t-PA transcript were apparent 10–12 h after IR (15) . Both NF-{kappa}B and Sp1/RCP DNA binding as well as IEG, t-PA, TK, and certain xip expression demonstrated inducible activity at low levels of IR, but were down-regulated after high doses (>600 cGy) (Fig. 1) (7) . The significance of the coordinate activation of Sp1/RCP and NF-{kappa}B DNA binding after IR is not known nor is the mechanism of reduced TF binding and subsequent reduced gene expression after high doses of IR. Sp1/RCP and NF-{kappa}B proteins may synergistically interact on certain promoter regions (33 , 39 40 41) . These data suggest that these two TFs may be activated coordinately after IR and work cooperatively to control gene transcription in response to DNA damage in certain cells.

The IR-activated DNA binding of Sp1/RCP to Sp1 consensus sites was very complex, resulting in three mobility-shifted DNA–protein complexes appearing as bands 1a, 1b, and 2. Only band 1a contained the Sp1 protein (Fig. 1A ), and DNA binding of the three bands increased at different rates after IR. Recently, RCP genes with conserved Sp1 DNA binding domain have been discovered (e.g., Sp2, Sp3, Sp4) (42) . Understanding the sequence of Sp1 and RCP binding to Sp1/RCE sites in certain responsive promoters after IR will be central to our understanding of the mechanisms and complexities behind IR-inducible gene transcription. It is interesting that we found no increases in AP-1 DNA binding activity in U1-Mel cells after IR (5 , 6) . We expected increases in this transcription factor, since other laboratories have described increases in c-jun/c-fos heterodimeric DNA binding after IR in other cell systems (43 , 44) . Our data indicate that at clinically relevant doses of IR (200 cGy), IEG induction may occur by AP1-independent but Sp1/RCP-dependent mechanisms in radioresistant human U1-Mel melanoma cells. We propose that such induction occurs through Sp1/RCP in combination with NF-{kappa}B. Further research is required to test this hypothesis, and will be essential before one could logically use IR-responsive promoters (XRE) for gene therapy (16 , 45) .

How does Sp1/RCP and NF-{kappa}B activation of DNA binding occur after IR? Sp1 and I{kappa}B{alpha} (NF-{kappa}B inhibitor) are substrates for DNA-dependent protein kinase (DNA-PK) in vitro (18 , 19 , 21) . This kinase (DNA-PKcs, catalytic subunit) requires free DNA ends and associates with the Ku antigen (46) , an heterodimer of p70 (Ku70) and p80 (Ku80) protein subunits. DNA-PK is intimately involved in DNA double-strand break repair (47 , 48) . Phosphorylation of Sp1 increases its transcriptional activity (31 , 32) , whereas phosphorylation and subsequent proteolysis of I{kappa}B{alpha} release and activate NF-{kappa}B (37) . p53 is also a substrate for DNA-PK in vitro, and it is feasible that phosphorylation of p53 at Ser15 by DNA-PK may stabilize p53 and increase its half-life in the nucleus (49) . Previously published data proposed that DNA-PK acts upstream of p53 in response to DNA damage (20) . We hypothesize that DNA-PK is a DNA damage checkpoint modulator (7) . It recognizes and participates in the repair of single- and double-strand DNA breaks generated by IR. In response, DNA-PK may transduce the signal of DNA damage through phosphorylation, perhaps coordinately activating Sp1, NF-{kappa}B (via I{kappa}B{alpha} phosphorylation), or p53. As our data in Figs. 1 and 2 indicate, the levels of these TFs in the nucleus appear to be coordinately regulated; data suggest that the extent of damage initially created may determine the spectrum of responses observed. Low doses of IR would activate high-affinity substrates, such as Sp1, whereas relatively higher doses of IR would be required to activate sufficient DNA-PKcs enzyme activity to phosphorylate low-affinity substrates such as p53. The affinities may be altered by the growth status of the cell. Confluent U1-Mel cells were used exclusively in our system.

We speculate that DNA-PK phosphorylates Sp1 and possibly other RCPs in vivo, resulting in a cellular decision to carry out DNA repair after low doses (clinically relevant) of IR. It has been shown that both Ku80 and DNA-PKcs gene expression are Sp1 dependent (50 , 51) . In contrast, high doses of IR create badly damaged cells with large amounts of DNA breaks resulting in peak DNA-PK activation, leading to phosphorylation and stabilization of p53, and thereby increased p53 nuclear levels (Fig. 3) (52 , 53) . Sp1/RCP binding rapidly decreased with high doses of IR. This may actually be regulated by p53 expression (54) . We speculate that the inverse relationship between Sp1/RCP and p53 binding may control a cellular decision to undergo DNA repair or p53-dependent apoptosis (28 , 55) . Other candidates for this upstream modulator are the ATM (ataxia telangiectasia mutation) or c-abl kinases. Emerging data suggest that the ATM kinase phosphorylates and regulates p53 (56 , 57) and I{kappa}B{alpha} (14 , 58) .

Functional knockout experiments (Fig. 3 and Table 1 ) further suggest that certain TFs may be directly or indirectly involved in cell survival or cell death. Disruption of pRb (E7 transfection), and therefore Sp1 regulation, resulted in loss of the radioresistant phenotype of U1-Mel cells (Fig. 3B ); the significance of Sp1 vs. other factors regulated by pRb cannot be distinguished at this time. However, the data presented here clearly indicate that pRb is a major factor in protecting cells from apoptosis, as well as from the generation of polyploid cell populations (Table 1) .

In contrast, deregulation of NF-{kappa}B by the I{kappa}B{alpha} S32/36A dominant-negative mutant protein enhanced the radioresistance of U1-Mel cells (Fig. 3C ). These data appear contrary to previous studies showing an anti-apoptotic role for NF-{kappa}B after tumor necrosis factor {alpha} exposure (26 , 59) .

Similar increases in polyploid U1-Mel-E6 and U1-Mel-E7 cell populations at similar time frames after IR exposure were noted (Table 1) . These data highlight the importance and consequences of cell cycle checkpoint abrogation. Using these model systems, we hope to better understand the role(s) of IR-inducible TFs and genes in cell cycle checkpoints, radiosensitivity, PLDR, apoptosis and in the maintenance of genomic stability, which will be clinically important to sensitize radioresistant tumors for radiotherapy.


   ACKNOWLEDGMENTS
 
Funding for this research was provided to D.A.B. from NIH grants CA-EY67995 and CA-78530. The authors are grateful to Roger and Jeanne DeMerrit for their pilot grant support in the early stages of this work. We thank Ms. Kelly Hosley, Colleen Tagliarino, Drs. Timothy J. Kinsella, and Jack Little for their helpful discussions.


   FOOTNOTES
 
Received for publication July 27, 1999. Revised for publication September 27, 1999.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Weichselbaum, R. R., Dahlberg, W., Little, J. B. (1985) Inherently radioresistant cells exist in some human tumors. Proc. Natl. Acad. Sci. USA 82,4732-4735[Abstract/Free Full Text]
  2. Rubin, P. (1993) Clinical Oncology: A Multidisciplinary Approach for Physicians and Students 7th Ed, Vol. 306 ,72 W. B. Saunders Philadelphia.
  3. Boothman, D. A., Trask, D. K., Pardee, A. B. (1989) Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Res 49,605-612[Abstract/Free Full Text]
  4. Boothman, D. A., Meyers, M., Fukunaga, N., Lee, S. W. (1993) Isolation of X-ray-inducible transcripts from radioresistant human melanoma cells. Proc. Natl. Acad. Sci. USA 90,7200-7204[Abstract/Free Full Text]
  5. Sahijdak, W. M., Yang, C. R., Zuckerman, J. S., Meyers, M., Boothman, D. A. (1994) Alterations in transcription factor binding in radioresistant human melanoma cells after ionizing radiation. Radiat. Res. 138,S47-S51[Medline]
  6. Boothman, D. A., Fukunaga, N., Wang, M. (1994) Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Res. 54,4618-4626[Abstract/Free Full Text]
  7. Boothman, D. A., Burrows, H. L., Yang, C. R., Davis, T. W., Wuerzberger, S. M., Planchon, S. M., Odegaard, E., Lewis, J. E., Pink, J., Meyers, M., Patten, C. W., Sharda, N., Kinsella, T. J. (1997) Damage-sensing mechanisms in human cells after ionizing radiation. Stem Cells 15,27-42
  8. Udvadia, A. J., Rogers, K. T., Horowitz, J. M. (1992) A common set of nuclear factors bind to promoter elements regulated by the retinoblastoma protein. Cell Growth Differ 3,597-608[Abstract]
  9. Robbins, P. D., Horowitz, J. M., Mulligan, R. C. (1990) Negative regulation of human c-fos expression by the retinoblastoma gene product [published erratum appears in Nature (London) 1991, Vol. 351, p. 6325]. Nature (London) 346,668-671[Medline]
  10. Kim, S. J., Wagner, S., Liu, F., O’Reilly, M. A., Robbins, P. D., Green, M. R. (1992) Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (London) 358,331-334[Medline]
  11. Kim, S. J., Onwuta, U. S., Lee, Y. I., Li, R., Botchan, M. R., Robbins, P. D. (1992) The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12,2455-2463[Abstract/Free Full Text]
  12. Udvadia, A. J., Rogers, K. T., Higgins, P. D., Murata, Y., Martin, K. H., Humphrey, P. A., Horowitz, J. M. (1993) Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc. Natl. Acad. Sci. USA 90,3265-3269[Abstract/Free Full Text]
  13. Meek, D. W. (1998) New developments in the multi-site phosphorylation and integration of stress signaling at p53. Int. J. Radiat. Biol. 74,729-377[Medline]
  14. Lee, S. J., Dimtchev, A., Lavin, M. F., Dritschilo, A., Jung, M. (1998) A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kappaB. Oncogene 17,1821-1826[Medline]
  15. Boothman, D. A., Wang, M., Lee, S. W. (1991) Induction of tissue-type plasminogen activator by ionizing radiation in human malignant melanoma cells. Cancer Res 51,5587-5595[Abstract/Free Full Text]
  16. Boothman, D. A., Lee, I. W., Sahijdak, W. M. (1994) Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of X-ray-responsive elements for gene therapy. Radiat. Res. 138,S68-S71[Medline]
  17. Summers, W. C., Sarkar, S. N., Glazer, P. M. (1985) Direct and inducible mutagenesis in mammalian cells. Cancer Surveys 4,517-528[Medline]
  18. Jackson, S. P., MacDonald, J. J., Lees-Miller, S., Tjian, R. (1990) GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63,155-165[Medline]
  19. Basu, S., Rosenzweig, K. R., Youmell, M., Price, B. D. (1998) The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem. Biophys. Res. Commun. 247,79-83[Medline]
  20. Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., Lee, P. W. (1998) DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature (London) 394,700-704[Medline]
  21. Liu, L., Kwak, Y. T., Bex, F., Garcia-Martinez, L. F., Li, X. H., Meek, K., Lane, W. S., Gaynor, R. B. (1998) DNA-dependent protein kinase phosphorylation of I-kappaB alpha and I-kappaB beta regulates NF-kappaB DNA binding properties. Mol. Cell. Biol. 18,4221-4234[Abstract/Free Full Text]
  22. Anderson, C. W., Lees-Miller, S. P. (1992) The nuclear serine/threonine protein kinase DNA-PK. Crit. Rev. Eukaryotic Gene Expression 2,283-314[Medline]
  23. Boothman, D. A., Wang, M., Schea, R. A., Burrows, H. L., Strickfaden, S., Owens, J. K. (1992) Posttreatment exposure to camptothecin enhances the lethal effects of x-rays on radioresistant human malignant melanoma cells. Int. J. Radiat. Oncol. Biol. Physics 24,939-948[Medline]
  24. Boothman, D. A., Bouvard, I., Hughes, E. N. (1989) Identification and characterization of X-ray-induced proteins in human cells. Cancer Res 49,2871-2878[Abstract/Free Full Text]
  25. Boothman, D. A., Greer, S., Pardee, A. B. (1987) Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor. Cancer Res 47,5361-5366[Abstract/Free Full Text]
  26. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., Verma, I. M. (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB [see comments]. Science 274,787-789[Abstract/Free Full Text]
  27. Wuerzberger, S. M., Pink, J. J., Planchon, S. M., Byers, K. L., Bornmann, W. G., Boothman, D. A. (1998) Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta- lapachone. Cancer Res 58,1876-1885[Abstract/Free Full Text]
  28. Chen, L. I., Nishinaka, T., Kwan, K., Kitabayashi, I., Yokoyama, K., Fu, Y. H., Grunwald, S., Chiu, R. (1994) The retinoblastoma gene product (pRb) stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14,4380-4389[Abstract/Free Full Text]
  29. Kastan, M. B., Canman, C. E., Leonard, C. J. (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14,3-15[Medline]
  30. Udvadia, A. J., Templeton, D. J., Horowitz, J. M. (1995) Functional interactions between the retinoblastoma (pRb) protein and Sp-family members: superactivation by pRb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA 92,3953-3957[Abstract/Free Full Text]
  31. Vlach, J., Garcia, A., Jacque, J. M., Rodriguez, M. S., Michelson, S., Virelizier, J. L. (1995) Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid. Virology 208,753-761[Medline]
  32. Alroy, I., Soussan, L., Seger, R., Yarden, Y. (1999) Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol. Cell. Biol. 19,1961-1972[Abstract/Free Full Text]
  33. Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., Nabel, G. J. (1993) A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J 12,3551-3558[Medline]
  34. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., Fornace, A. J., Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71,587-597[Medline]
  35. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., Kastan, M. B. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89,7491-7495[Abstract/Free Full Text]
  36. Goodrich, D. W., Lee, W. H. (1992) Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53 [published erratum appears in Nature (London) 1992, Vol. 360, p. 6403]. Nature (London) 360,177-179[Medline]
  37. Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., Baeuerle, P. A. (1995) Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 14,2876-2883[Medline]
  38. Waldman, T., Lengauer, C., Kinzler, K. W., Vogelstein, B. (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 [see comments]. Nature (London) 381,713-716[Medline]
  39. Wu, R. L., Chen, T. T., Sun, T. T. (1994) Functional importance of an Sp1- and an NF-{kappa}B-related nuclear protein in a keratinocyte-specific promoter of rabbit K3 keratin gene. J. Biol. Chem. 269,28450-28459[Abstract/Free Full Text]
  40. Hirano, F., Tanaka, H., Hirano, Y., Hiramoto, M., Handa, H., Makino, I., Scheidereit, C. (1998) Functional interference of Sp1 and NF-kappaB through the same DNA binding site. Mol. Cell. Biol. 18,1266-1274[Abstract/Free Full Text]
  41. Ueda, A., Okuda, K., Ohno, S., Shirai, A., Igarashi, T., Matsunaga, K., Fukushima, J., Kawamoto, S., Ishigatsubo, Y., Okubo, T. (1994) NF-kappa B and Sp1 regulate transcription of the human monocyte chime-attractant protein-1 gene. J. Immunol. 153,2052-2063[Abstract]
  42. Hagen, G., Muller, S., Beato, M., Suske, G. (1994) Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13,3843-3851[Medline]
  43. Hallahan, D. E., Virudachalam, S., Beckett, M., Sherman, M. L., Kufe, D., Weichselbaum, R. R. (1991) Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines [published erratum appears in Int. J. Radiat. Oncol. Biol. Phys. 1992, Vol. 22, p. 829]. Int. J. Radiat. Oncol. Biol. Physics 21,1677-1681[Medline]
  44. Datta, R., Rubin, E., Sukhatme, V., Qureshi, S., Hallahan, D., Weichselbaum, R. R., Kufe, D. W. (1992) Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc. Natl. Acad. Sci. USA 89,10149-10153[Abstract/Free Full Text]
  45. Weichselbaum, R. R., Hallahan, D. E., Sukhatme, V. P., Kufe, D. W. (1992) Gene therapy targeted by ionizing radiation. Int. J. Radiat. Oncol. Biol. Physics 24,565-567[Medline]
  46. Gottlieb, T. M., Jackson, S. P. (1993) The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72,131-142[Medline]
  47. Kirchgessner, C. U., Patil, C. K., Evans, J. W., Cuomo, C. A., Fried, L. M., Carter, T., Oettinger, M. A., Brown, J. M. (1995) DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267,1178-1183[Abstract/Free Full Text]
  48. Finnie, N. J., Gottlieb, T. M., Blunt, T., Jeggo, P. A., Jackson, S. P. (1995) DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 92,320-324[Abstract/Free Full Text]
  49. Fiscella, M., Ullrich, S. J., Zambrano, N., Shields, M. T., Lin, D., Lees-Miller, S. P., Anderson, C. W., Mercer, W. E., Appella, E. (1993) Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8,1519-1528[Medline]
  50. Ludwig, D. L., Chen, F., Peterson, S. R., Nussenzweig, A., Li, G. C., Chen, D. J. (1997) Ku80 gene expression is Sp1-dependent and sensitive to CpG methylation within a novel cis element. Gene 199,181-194[Medline]
  51. Fujimoto, M., Matsumoto, N., Tsujita, T., Tomita, H., Kondo, S., Miyake, N., Nakano, M., Nikawa, N. (1997) Characterization of the promoter region, first ten exons and nine intronexon boundaries of the DNA-dependent protein kinase catalytic subunit gene, DNA-PKcs (XRCC7). DNA Res 4,151-154[Abstract]
  52. Shaulsky, G., Goldfinger, N., Tosky, M. S., Levine, A. J., Rotter, V. (1991) Nuclear localization is essential for the activity of p53 protein. Oncogene 6,2055-2065[Medline]
  53. Shaulsky, G., Goldfinger, N., Ben-Ze’ev, A., Rotter, V. (1990) Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 10,6565-6577[Abstract/Free Full Text]
  54. Bargonetti, J., Chicas, A., White, D., Prives, C. (1997) p53 represses Sp1 DNA binding and HIV-LTR directed transcription. Cell. Mol. Biol. 43,935-949
  55. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., Vogelstein, B. (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10,1945-1952[Abstract/Free Full Text]
  56. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., Siliciano, J. D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281,1677-1679[Abstract/Free Full Text]
  57. Khanna, K. K., Keating, K. E., Kozlov, S., Scott, S., Gatei, M., Hobson, K., Taya, Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., Lavin, M. F. (1998) ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20,398-400[Medline]
  58. Jung, M., Kondratyev, A., Lee, S. A., Dimtchev, A., Dritschilo, A. (1997) ATM gene product phosphorylates I kappa B-alpha. Cancer Res 57,24-27[Abstract/Free Full Text]
  59. Bakker, T. R., Reed, D., Renno, T., Jongeneel, C. V. (1999) Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int. J. Cancer 80,320-323[Medline]



This article has been cited by other articles:


Home page
CarcinogenesisHome page
N. K. Clemo, T. J. Collard, S. L. Southern, K. D. Edwards, M. Moorghen, G. Packham, A. Hague, C. Paraskeva, and A. C. Williams
BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-{kappa}B activity
Carcinogenesis, April 1, 2008; 29(4): 849 - 857.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. A. Olofsson, C. M. Kelly, J. Kim, S. M. Hornsby, and J. Azizkhan-Clifford
Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
Mol. Cancer Res., December 1, 2007; 5(12): 1319 - 1330.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Iwahori, N. Shirata, Y. Kawaguchi, S. K. Weller, Y. Sato, A. Kudoh, S. Nakayama, H. Isomura, and T. Tsurumi
Enhanced Phosphorylation of Transcription Factor Sp1 in Response to Herpes Simplex Virus Type 1 Infection Is Dependent on the Ataxia Telangiectasia-Mutated Protein
J. Virol., September 15, 2007; 81(18): 9653 - 9664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Dasari, J. N. Bartholomew, D. Volonte, and F. Galbiati
Oxidative Stress Induces Premature Senescence by Stimulating Caveolin-1 Gene Transcription through p38 Mitogen-Activated Protein Kinase/Sp1-Mediated Activation of Two GC-Rich Promoter Elements.
Cancer Res., November 15, 2006; 66(22): 10805 - 10814.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
S Araki, S Israel, K S Leskov, T L Criswell, M Beman, D Y Klokov, L Sampalth, K E Reinicke, E Cataldo, L D Mayo, et al.
Clusterin proteins: stress-inducible polypeptides with proposed functions in multiple organ dysfunction
Br. J. Radiol., January 1, 2005; Supplement_27(1): 106 - 113.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. H. AN, J. KIM, and J. SEONG
Redox Signaling by Ionizing Radiation in Mouse Liver
Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Wang, A. Meng, H. Lang, S. A. Brown, J. L. Konopa, M. S. Kindy, R. A. Schmiedt, J. S. Thompson, and D. Zhou
Activation of Nuclear Factor {kappa}B In vivo Selectively Protects the Murine Small Intestine against Ionizing Radiation-Induced Damage
Cancer Res., September 1, 2004; 64(17): 6240 - 6246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Fujioka, C. Schmidt, G. M. Sclabas, Z. Li, H. Pelicano, B. P